|
PXL/HO/Cir-098/2026-27 Date: 11.11.2026
Hyderabad
Subject: Business Opportunity – Saudi Arabian Pharmaceutical Company Seeking Indian Manufacturers for Product Registration and Commercialisation
Dear Members,
PHARMEXCIL has received an expression of interest from Al Hobail Medical Company, Saudi Arabia, seeking to establish business collaborations with Indian pharmaceutical manufacturers for the registration and commercialisation of pharmaceutical products in the Saudi Arabian market.
The company has identified a specific list of pharmaceutical products for which it is exploring potential Indian manufacturing partners. The detailed product requirement list is attached herewith for the reference of interested members.
Proposed Business Arrangement
Under the proposed arrangement, the selected products would be registered in Saudi Arabia with Al Hobail Pharmaceuticals as the Marketing Authorisation Holder (MAH) and subsequently commercialised through the following channels:
-
NUPCO
-
Ministry of Health (MOH)
-
Private healthcare and pharmaceutical distribution channels
Regulatory Requirements
Interested Indian manufacturers should preferably have the following regulatory documentation and capabilities:
-
Completed or ready-to-submit CTD/eCTD dossiers.
-
Valid GMP certificates and Certificate of Pharmaceutical Product (COPP).
-
Valid manufacturing licences and product permissions.
-
Zone IVb stability data.
-
Bioequivalence (BE) study reports, wherever applicable.
Expression of Interest from Member Companies
PHARMEXCIL member companies having suitable product portfolios and the requisite regulatory documentation are invited to explore this business opportunity.
Interested companies are requested to share the following details:
-
Company profile and manufacturing facility details.
-
List of products matching the requirements of Al Hobail Medical Company.
-
Availability of regulatory documentation for the proposed products.
-
Name and contact details of the authorised representative for further coordination.
Submission of Interest and Contact Details
Interested PHARMEXCIL member companies are requested to share their company profile, matching product portfolio and details of available regulatory documentation directly with the following contact:
Mr. Mohammed Sadiq Ahmed
Tender Manager
Al Hobail Medical Company
3155, Al Aqiq, Riyadh 13515, Kingdom of Saudi Arabia
Tel: +966 92 000 6647
Mobile: +966 50 333 2898
Email: tm@al-hobail.com
Website: https://al-hobail.com
Members are encouraged to communicate their interest at the earliest and explore potential business collaborations directly with Al Hobail Medical Company.
With Regards,
Raja Bhanu K
Director General
Encl: list
|
